RAS Family Gene Mutation: Clinical Trials

2 trials for RAS Family Gene Mutation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Terminated 1
Phase 11Completed 1

Follow RAS Family Gene Mutation: new trials by email Literature Review of RAS Family Gene Mutation trials Research Report on RAS Family Gene Mutation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies
Allogeneic Hematopoietic Stem Cell Transplantation, Irradiated Allogeneic Cells - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia in Remission
Early Phase 1TerminatedRutgers, The State University of New Jersey22020-10-262023-06-26
Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery
Laboratory Biomarker Analysis, Trametinib, Trifluridine and Tipiracil Hydrochloride - Metastatic Colon Carcinoma, Metastatic Colorectal Carcinoma
Phase 1CompletedCity of Hope Medical Center262018-04-112024-04-08

Narrower conditions

Chromosome 17 deletion (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Hematologic Neoplasms (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoma, T-Cell (1)  ·  Multiple Myeloma (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasm, Residual (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Rectal Neoplasms (1)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Blood Protein Disorders (1)  ·  Bone Marrow Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Hemostatic Disorders (1)  ·  Immune System Diseases (1)

Interventions

Trifluridine (1)  ·  trametinib (1)  ·  trifluridine tipiracil drug combination (1)

Sponsors

City of Hope Medical Center (1)  ·  Rutgers, The State University of New Jersey (1)

Countries

United States (2)

Top investigators

Marwan G Fakih (1)  ·  Roger Strair (1)

Results publications

PMID 35738999

NIH funding

P30CA033572 (1), P30CA072720 (1)